Insulet (NASDAQ:PODD – Free Report) had its price objective upped by Royal Bank Of Canada from $365.00 to $370.00 in a research note released on Friday morning,Benzinga reports. The brokerage currently has an outperform rating on the medical instruments supplier’s stock. Several other research firms have also commented on PODD. Leerink Partners raised their price [...]
Insulet (NASDAQ:PODD) Price Target Raised to $370.00
